Presideo, Verisign partner, gain Medquist as customer

Article

Presideo, Verisign partner, gain Medquist as customerPresideo, a firm specializing in digital identity management in healthcare, and Verisign, a firm concentrating on security infrastructure for e-business, have partnered to provide services to

Presideo, Verisign partner, gain Medquist as customer

Presideo, a firm specializing in digital identity management in healthcare, and Verisign, a firm concentrating on security infrastructure for e-business, have partnered to provide services to the healthcare industry. Verisign will combine its 24/7 managed trust services infrastructure with Presideo’s identity management products to develop online physician credentialing; biometric authentication; interoperability services; and a policy, legal, and business framework specific to healthcare. Presideo and Verisign will jointly market these security services.

The firms have already sold Medquist, a transcription services vendor owned by Philips, on their joint offering. Medquist will embed Internet security infrastructure and digital certificates into existing products and Medquist.net products.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.